Karo Pharma AB buy Morgan Stanley
Start price
26.06.25
/
50%
€5.44
Target price
26.06.26
€45.35
Performance (%)
-
End price
27.06.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karo Pharma AB | - | - | - |
| iShares Core DAX® | -1,11 % | 0,20 % | 1,21 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % | 25,87 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % | 50,97 % |
| iShares S&P 500 | -1,79 % | 0,99 % | 21,07 % |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten